GLOW
The skin & repair trio — GHK-Cu + BPC-157 + TB-500 in a single injection.
iThe essentials in 10 seconds
- Ready-to-use blend: GHK-Cu + BPC-157 + TB-500 in a single vial
- The skin, hair and repair trio: collagen, tendons, inflammation
- Subcutaneous injection with the pen, once daily — 4- to 6-week cycle
- The "glow" protocol: skin radiance and recovery in a single injection
IWhat is GLOW?
GLOW combines three complementary peptides in a single vial: GHK-Cu (copper peptide), which restarts collagen and elastin; BPC-157, which repairs tendons and the intestinal mucosa; and TB-500, which promotes tissue flexibility and the migration of repair cells. The blend is dosed 5:1:1 — 50 mg of GHK-Cu to 10 mg of each of the other two, i.e. 70 mg in total — making it a protocol oriented toward skin and tissue quality.
Recently introduced blend: no clinical trial has evaluated the combination of these three peptides. Doses are extrapolated from the protocols of each component. The high copper content requires cycles with a break.
The molecules presented on this site are innovative and fall under experimental use. Human data remain limited: a studied mechanism or a preclinical observation is not sufficient to demonstrate a benefit. The regulatory status in Morocco is not established for most of these peptides. Any use is decided within the framework of a medical consultation, with follow-up — never alone, never without an assessment.
IIThe benefits
GHK-Cu stimulates the synthesis of collagen and elastin: firmer skin, brighter complexion.
Supports the hair follicle and scalp quality, as a complement to a hair protocol.
BPC-157 and TB-500 cover tendon and muscle repair and shorten recovery.
Reduces inflammation at the injury site and in chronic joint pain.
BPC-157 protects the intestinal mucosa — permeability and digestive inflammation.
Three peptides in one vial: fewer steps and fewer dosing errors than with three separate vials.
IIIRecommendations & how to use
Route: subcutaneous injection with the injection pen (32G · 4 mm needle, changed at each injection) · Dose: 10 units (0.10 ml)/day ≈ 1.7 mg GHK-Cu + 0.33 mg BPC-157 + 0.33 mg TB-500 · Cycle: 4 to 6 weeks then a 2- to 4-week break · Storage: refrigerated (2–8 °C), protected from light, 28 days after reconstitution.
The blend is rich in GHK-Cu: in case of injury, TB-500 should be supplemented separately.
| Dosage | Price |
|---|---|
| 70 mg | Provided on request |
Prices are not published online: they are provided on request, during a consultation or by telephone.
IVThe two protocols
Goal: improve radiance, skin firmness and hair quality.
Follow-up: before/after photo, skin quality, hair density, tolerance.
Goal: accelerate the repair of a tendon or muscle injury and calm inflammation.
Follow-up: progression of pain and mobility; combine rehabilitation and rest when indicated.
VProtocol rules
- Respect the break between two cycles (copper load)
- Daily sun protection (SPF)
- Regular skin hydration
- Before/after follow-up photos
- Keep the cartridge in the refrigerator (2–8 °C)
- No injection without medical training (pen)
- Do not chain cycles without a break
- Avoid contact with the eyes
- Progressive cancer, pregnancy: medical advice
- Known allergy to copper or peptides: medical advice
VIYour journey in 3 steps
Evaluation of skin, hair and injuries, reference photos, protocol provided.
Daily injection with the pen, monitoring of tolerance and pain.
Before/after comparison, decision on the break and the next cycle.
VIISide effects & level of evidence
- Injection-site reaction (pain, redness, induration)
- Fatigue, headache
- Dizziness, nausea
- Cumulative effects of the three components (see fiches)
- Active cancer or cancer history
- Pregnancy, breastfeeding
- Uncontrolled autoimmune disease: caution
- Hypersensitivity to any component
Non-exhaustive list based on the available literature and known class effects; it replaces neither a product label nor an individual medical assessment.
VIIIPublications & references
- Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic ReviewVasireddi et al. · HSS J · 2025 · PMID 40756949
- Stable Gastric Pentadecapeptide BPC 157 and Wound HealingSeiwerth et al. · Front Pharmacol · 2021 · PMID 34267654
- Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene DataPickart L, Margolina A · Int J Mol Sci · 2018 · PMID 29986520
Combination GHK-Cu / BPC-157 / TB-500: the available literature concerns the components taken separately, not the combination.
Documentary references: the existence of a publication establishes neither efficacy nor safety for personal use. The regulatory status in Morocco must be verified.